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Abstract
Purpose Depression is common in adolescents and long-chain polyunsaturated fatty acids (LCPUFA) are suggested to be 
associated with depression. However, research in adolescents is limited. Furthermore, self-esteem has never been studied in 
relation to LCPUFA. The objective here was to determine associations of depression and self-esteem with eicosapentaenoic 
acid (EPA), docosahexaenoic acid (DHA), Omega-3 Index (O3I), n-6 docosapentaenoic acid (n-6 DPA, also called Osbond 
acid, ObA), n-3 docosapentaenoic acid (DPA), and arachidonic acid (AA) concentrations in blood of adolescents attending 
lower general secondary education (LGSE).
Methods Baseline cross-sectional data from a krill oil supplementation trial in adolescents attending LGSE with an O3I ≤ 5% were 
analysed using regression models built with the BayesFactor package in R. Fatty acids and O3I were determined in blood. Par-
ticipants filled out the Centre for Epidemiologic Studies Depression (CES-D) scale and the Rosenberg Self-Esteem scale (RSE).
Results Scores indicative of depression (CES-D ≥ 16) were found in 29.4% of the respondents. Of all fatty acids, we found 
extreme evidence [Bayes factor (BF) > 100] for a weak negative association between ObA and depression score [− 0.16; 95% 
credible interval (CI) − 0.28 to − 0.04;  BF10 = 245], and substantial evidence for a weak positive association between ObA 
and self-esteem score (0.09; 95% CI, − 0.03 to 0.20;  BF10 = 4). When all fatty acids were put in one model as predictors of 
CES-D or RSE, all of the 95% CI contained 0, i.e., no significant association.
Conclusion No evidence was found for associations of DHA, EPA and O3I with depression or self-esteem scores in LGSE 
adolescents with O3I ≤ 5%. The associations of higher ObA status with lower depression and higher self-esteem scores 
warrant more research.
Keywords Adolescents · Depressed mood · Long-chain polyunsaturated fatty acid · Self-esteem · Omega-3 Index · Healthy 
youth · High schoolers · Brain functioning
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DHA  Docosahexaenoic acid, C22:6n-3
DPA  Docosapentaenoic acid, 22:5n-3
EPA  Eicosapentaenoic acid, C20:5n-3
LCPUFA  Long-chain polyunsaturated fatty acid
LGSE  Lower general secondary education
O3I  Omega 3-Index
ObA  Osbond acid, n-6 docosapentaenoic acid, 
22:5n-6
RSE  Rosenberg Self Esteem Questionnaire
Introduction
Depression affects approximately 350 million people world-
wide and is especially common in adolescence [1, 2]. It has 
been suggested that 14–25% of adolescents will experience 
at least one depressive episode before the age of 18 [3]. Ado-
lescent depression has been associated with many adverse 
short- and long-term outcomes such as poor social relation-
ships, lower concentration, lower school performance, nega-
tive physical and mental health outcome, and increased risk 
for adult depression [4–7]. Subthreshold depression (i.e., 
depressive symptoms are present but criteria for a major 
depression are not met) is also common, with a life-time 
prevalence up to age 17 varying between 5.3 and 12% [8]. 
Subthreshold depression has also been related to poorer 
quality of life, socio-emotional dysfunction, and increased 
risk for the development of major depression [9, 10].
Depression is a complex and heterogeneous disorder and 
its aetiology is not completely understood. Many factors 
have been related to the commencement of depression: her-
itability, childhood adversity, acute stressful live events, and 
chronic stress among others [11–15]. Depression can lead 
to changes in brain structures, production of proinflamma-
tory factors, neuroinflammation, alteration of the immune 
system, dysfunction and elevation of homocysteine levels, 
blood flow abnormalities, and a decrease in glucose metabo-
lism [16–21].
Long-chain polyunsaturated fatty acids (LCPUFA) have 
been suggested to be associated with depression. LCPUFA 
are important constituents of all cell membranes and are 
involved in many aspects of brain functioning such as neu-
ronal membrane fluidity, brain blood flow, signal transduc-
tion and neurotransmission [22, 23]. Moreover, LCPUFA 
have been suggested to modulate neuroendocrine factors, 
have anti-inflammatory properties and may in this way help 
counteract or reduce the neurobiological changes associated 
with depression [24]. Multiple observational studies have 
shown that blood and brain eicosapentaenoic acid (EPA, 
C20:5n-3) and docosahexaenoic acid (DHA, C22:6n-3) con-
centrations are lower in people with a depression compared 
to non-depressed controls [25–28]. Moreover, a number of 
intervention trials have shown a positive effect of LCPUFA 
supplementation on depression [29–32], but not all [33, 34].
Studies in adolescents either focus on adolescents in treat-
ment for depression [35, 36], on dietary intake of LCPUFA 
[37, 38], or on adolescents and adults together [39]. There is 
only one study, to the best of our knowledge, which investi-
gates LCPUFA status and depressive symptoms in adoles-
cents from the general population.
Mamalakis et al. showed a negative association between 
EPA measured in adipose tissue and depression score meas-
ured by the Centre for Epidemiologic Studies Depression 
(CES-D) scale after correction for adiponectin, indicating 
that a lower EPA status was associated with more depression. 
Furthermore, they showed a positive association between 
dihomo-gamma linolenic acid (DGLA, C20:3n-6) in adi-
pose tissue and depression score measured with the Beck 
Depression Inventory, again after correction for adiponec-
tin, indicating that a lower DGLA status is associated with 
less depression. Last, depression occurs more often in adults 
and adolescents with a lower socioeconomic status [40, 41]. 
However, the association between the Omega-3 Index (O3I) 
measured in blood and depression in adolescents with a lower 
education level has, to our knowledge, not yet been studied.
Thus, little is known about the association between 
omega-3 fatty acids and depression in healthy adolescents 
of a lower educational level. We investigated the association 
between the O3I, measured in blood and depression in a 
sample of second year students of lower general secondary 
education (LGSE). The O3I is the amount of EPA + DHA 
expressed as a percentage of total identified fatty acids after 
response factor correction and a correction for the fact that 
whole blood was used instead of the normally used eryth-
rocytes. We expected that a higher O3I would be associated 
with less depressive feelings. Second, associations between 
DHA, EPA, docosapentaenoic acid (DPA, 22:5n-3), arachi-
donic acid (AA, 20:4n-6), and Osbond acid (ObA also called 
n-6 docosapentaenoic acid, 22:5n-6) measured in blood and 
depression were explored. We focussed on AA, DHA and 
EPA because they are implicated to play a role in mental 
health [42], whereas ObA is considered to be a functional 
shortage indicator of DHA [43] and DPA as the major inter-
mediate between DHA and EPA. Therefore, it was expected 
that higher DHA, EPA and DPA were associated with lower 
depression scores, and that higher AA and ObA were associ-
ated with higher depression scores in adolescents. Further-
more, exploratively, we estimated the associations of the 
fatty acids with self-esteem. Self-esteem is a core construct 
of mental health as it represents a person’s overall evaluation 
of his or her own worth [44]. Low self-esteem has been asso-
ciated with poor health behaviour and many forms of mental 
illness, including an association between low self-esteem 
and major depression in adolescents [44–46] and even nega-
tive long-term physical and mental health outcomes [45, 47]. 
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However, to our knowledge, studies are lacking that explore 
an association between fatty acids and self-esteem.
Methods
This study used baseline data from a large double-blind, 
randomised, placebo controlled intervention study 
(Food2Learn) to study the effect of 1 year of krill oil supple-
mentation on cognitive performance, academic achievement, 
and mental well-being of students in the second year of 
LGSE. Full details about the cohort and measurements have 
been reported previously [48]. Food2Learn was approved 
by the Medical Ethical Committee of Atrium-Orbis-Zuyd 
Hospital Heerlen, the Netherlands (NL45803.096.13). Each 
participant as well as parent(s) and/or guardian(s) provided 
written informed consent for participation in the study. 
Food2Learn is registered at The Netherlands Trial Register 
(NTR4082) and at Clinicaltrials.gov (NCT02240264).
Data collection
Students of 17 schools offering LGSE in the Netherlands 
participated in Food2Learn. In the Netherlands, secondary 
education is divided into three levels: pre-university, higher 
general and lower general secondary education (LGSE). 
Approximately 38% of all adolescents in the Netherlands 
attend LGSE, which is again subdivided into four levels; 
for the current study, students from the highest sublevel, 
the theoretical learning pathway (TLP), were recruited. 
Approximately 40% of students attending LGSE are in the 
TLP [49]. We approached students in the second year of the 
LGSE-TLP, who are between 13 and 15 years of age. LGSE-
TLP students at participating schools were approached in a 
classroom setting and the study was explained orally by a 
research assistant who also used video material to support 
the presentation. Students then received an information let-
ter and were asked to discuss their participation with their 
parent(s) and/or guardian(s). If students wanted to partici-
pate, they had to hand in an informed consent form signed 
by both themselves and their parent(s) and/or guardian(s). 
After informed consent was received the student received a 
finger prick to determine the O3I. Only students with a low 
O3I (defined as O3I ≤ 5%) could participate in the study as 
this was a selection criterion of the main Food2Learn study, 
as it is to be expected that an effect of supplementation is 
more likely in those with a low baseline O3I. Thus, partici-
pants with an O3I > 5% were not included in the study. At 
baseline, participants filled out a number of questionnaires 
to determine mood status and self-esteem, and to collect 
information with respect to a number of covariates.
Blood analyses
A finger prick was administered by a trained researcher or 
research assistant with an automated one-time-use lancet; 
blood was collected on filtre paper specially prepared with a 
proprietary antioxidant. Blood acid compositions were ana-
lysed according to the HS-Omega-3  Index® methodology 
as described previously [50, 51]. Fatty acid methyl esters 
were generated by acid transesterification and analysed by 
gas chromatography using hydrogen as carrier gas. Fatty 
acids were identified by comparison with a standard mixture 
of fatty acids (GLC-727, Nuchek Prep, Elysian, Minnesota, 
USA). Results are given as the O3I, which is EPA + DHA 
expressed as a percentage of total identified fatty acids after 
response factor correction and a correction for the fact that 
whole blood was used instead of erythrocytes [50]. Typi-
cally, the coefficient of variation for EPA plus DHA is 5%. 
Analyses are quality-controlled according to DIN ISO. 
Furthermore, 26 other fatty acids were determined. We 
focussed on AA, DHA, EPA, ObA, and DPA. The O3I has 
been related to mental health in earlier studies investigating 
depression, bipolar disorder, and schizophrenia [52–55].
Questionnaires
Centre for Epidemiologic Studies Depression scale
Depressive feelings were assessed with the Dutch version 
of the CES-D scale [56], one of the most commonly used 
screening tools for depression that has been shown to be 
able to distinguish between depressed and non-depressed 
individuals in both clinical and community populations 
[56]. The questionnaire consists of 20 questions assessing 
whether six symptoms of depression were experienced by 
the participant in the last week. The CES-D has shown a 
high internal reliability in adolescents (α = 0.88) [57]. The 
measured symptoms include depressed mood, guilt/worth-
lessness, helplessness/hopelessness, psychomotor retarda-
tion, loss of appetite, and sleep disturbance. For each ques-
tion, the participants have to indicate whether a symptom 
occurred seldom or never (< 1 day), sometimes or a few 
times (1–2 days), often (3–4 days), or most of the time/
always (5–7 days). Each answer is scored as 0, 1, 2, or 3, 
respectively, and a total sum score is calculated. The score 
of the CES-D can thus vary between 0 and 60, with a higher 
score indicating more depressive feelings. It has been sug-
gested that depression should be considered as a continuum 
of increasing severity [8]. Therefore, the CES-D score was 
taken as a continuous variable in the current study. A CES-D 
score of ≥ 16 is, in general, accepted as an indication of 
depression [58], although some have suggested that a higher 
cut-off point might be more appropriate in adolescents, for 
example, a score of ≥ 22 [59]. We used a score of ≥ 16 in 
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descriptive analyses to indicate the number of adolescents 
with possible depression in our sample.
The Rosenberg Self-Esteem scale
Self-esteem was measured with the Dutch version of the 
Rosenberg Self-Esteem scale (RSE). The internal reliabil-
ity for the RSE has been found to be high in adolescents 
(α = 0.88) [60, 61] and construct validity with other meas-
ures of self-esteem has been shown [61]. The RSE consists 
of 10 questions scored on a 4-point response system (from 
strongly disagree = 0 to strongly agree = 3) requiring par-
ticipants to indicate their level of agreement with a series of 
statements about themselves. The total score of the RSE can 
vary between 0 and 30, with a higher score indicating higher 
self-esteem. The RSE score was also taken as a continuous 
variable.
Additional measures
Students filled out a questionnaire to assess covariates. The 
following variables were assessed, and included in the analy-
ses as covariates, as they are known to be associated with 
depression: BMI (weight/length2, self-reported) [62, 63], sex 
[64, 65], age in years [66], alcohol consumption (number of 
days per week that alcohol was consumed times units con-
sumed per consumption moment) [67], smoking (yes/no, yes 
if the participant had indicated to smoke more than 0 ciga-
rettes per week) [68], parental level of education (subdivided 
into eight levels from primary school to university) [69], 
pubertal status according to the categorisation suggested by 
Petersen et al. (subdivided into five levels from prepubertal 
to postpubertal) [70] (association between pubertal status 
and depression [71, 72]), and diagnosis which might influ-
ence learning (yes/no, e.g. autism, dyslexia, ADHD) [73, 
74].
Data analyses
Twelve participants had a maximum of two missing data 
points for the CES-D, these missing points were imputed 
by the person average score of the other CES-D items (if 
necessary reversed scored) as explained by Bono et al. [75]. 
For the RSE the same procedure was used. For all continu-
ous variables (all fatty acids, O3I, BMI, CES-D and RSE 
score) z-scores were calculated, i.e. a measure of how many 
standard deviations a data point is away from the mean score 
of the total sample.
We estimated the effect sizes for the association 
between the fatty acids and depression score/ self-esteem 
using Bayesian statistical approach. This approach makes 
it possible to incorporate prior knowledge about relation-
ships (called a prior), and, using a Bayes factor, to compare 
different models including the model representing the 
null hypotheses. Bayes  factor10 (BF) indicates how many 
times the alternative hypothesis  (H1, e.g. DHA is related 
to depression) is more likely compared to the null hypoth-
esis  (H0, e.g. DHA is not related to depression) or another 
hypothesis. It is, in general, accepted that a  BF10 between 
0.33 and 3 indicates that data do not favour either  H0 or 
 H1, the data are insensitive. A  BF10 for the comparison 
of  H1 to  H0 of less than 0.33 indicates evidence in favour 
of the  H0 and a  BF10 of more than 3 indicates evidence 
for the  H1 [76]. We considered the degree of evidence in 
favour of a model in accordance with Jeffrey’s classifica-
tion:  BF10 of 1 for no evidence; 1 to 3 (resp. when  BF10 
is 1/3 to 1 there is evidence in favour of null hypothesis) 
for anecdotal evidence in favour of alternative hypothesis; 
3–10 (1/10 to 1/3) for substantial evidence; 10–30 (1/30 
to 1/10) for strong evidence; 30–100 for very strong evi-
dence, (1/100 to 1/30); > 100 (< 1/100) for extreme evi-
dence [77]. Next to estimating  BF10 indices, we also used 
a top-down approach in which the full model is compared 
with a model with all factors but one (i.e., inclusion of all 
fatty acids but DHA).  BFomit indicates whether removing 
the factor from the model is deleterious, it is suggested 
that a  BFomit < 3 indicates that the factor is beneficial for 
the model and a  BFomit > 3 that removing the factor is bet-
ter for the model [78]. Because of the same denominator, 
 BF10 indices of different models with all possible com-
binations of covariates and predictors can be compared. 
For estimated effect sizes, a 95% credibility interval is 
provided that describes intervals where the parameters fall 
within a 95% probability given the observed data.
Analyses were executed in the R statistical environment 
(R studio version 3.3.2) with the package BayesFactor (ver-
sion 0.9.12-2). We used the standard settings of the pack-
age: the package considers the regression parameters to be 
distributed normally around zero, with negative effects and 
positive effects being equally likely, and smaller effects 
being more likely than larger effects. For the descriptive 
comparisons of characteristics between those with and with-
out depression, ANOVA and Chi-square analyses were car-
ried out. To explore the associations between each respective 
fatty acid or the O3I and depression respectively self-esteem, 
regression models were built predicting CES-D and RSE 
from the fatty acids. Next to the analyses with each fatty acid 
as individual predictor, two regression models were addi-
tionally built (one for depression and one for self-esteem) 
with all fatty acids as predictors in one analysis, which 
allows adjustment of the effect of a fatty acid for the effects 
of other fatty acids. All regression models were corrected for 
covariates, which were selected by comparing BFs of regres-
sion models with all possible combinations of covariates and 
the fatty acid. For estimation of the effect size 10.000 Monte 
Carlo iterations were run.
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Results
In total, 286 students provided informed consent. For three 
participants no blood sample was obtained. Additionally, 
one participant was excluded because of severe hyperven-
tilation after blood sampling, one participant withdrew 
consent before the study started, and one student quit 
during the first test session and was, therefore, excluded. 
Fourteen participants had an O3I > 5% and were, there-
fore, based on the protocol of the main Food2Learn study, 
excluded. Nine additional students did have an O3I > 5% 
but were not excluded before the start of the study, they 
were however excluded from analyses.
In total 257 students started the study; however, base-
line data on depression were available for 252 participants 
and self-esteems scores for 255 participants. Characteris-
tics of all participants are presented in Table 1. Do note 
that not all participants filled out the personal question-
naire, or did not fill out all questions, and data on level 
of parental education (LPE) and BMI are missing for 17 
participants. A total of 74 (29.4%) students (with CES-D 
score available) scored ≥ 16 on the CES-D indicative of 
a depression. When using the stricter criterion of ≥ 22, a 
total of 43 students (17.1%) could be classified as possibly 
having depression.
Comparing those with a depression (CES-D ≥ 16) 
and those without a depression (CES-D ≤ 15), there was 
extreme evidence  (BF10 = 1.1E + 4) that girls had more 
often a depression (42.3% with CES-D ≥ 16) than boys 
(15.6%). There was substantial evidence (BF = 5.64) that 
those with a depression had a higher BMI (M = 20.84, 
SD = 3.10) than those without depression (M = 19.64, 
SD = 2.93) and extreme evidence  (BF10 = 3.7E + 2) that 
those with a depression were further in puberty (82.9% 
were advanced or postpubertal) than those without 
depression (50.9% advanced or postpubertal). There was 
extreme evidence  (BF10 = 1.7E + 28) that self-esteem was 
significantly lower in those with a depression (M = 15.4, 
SD = 5.64) compared to those without (M = 23.88, 
SD = 3.96). Also when looking at the association between 
self-esteem and depression, their association was strong 
(self-esteem regressed on depression, regression coeffi-
cient = − 0.75 [95% credibility interval − 0.83 to − 0.67]; 
 BF10 = 3.51E43).
When comparing models predicting CES-D from poten-
tial confounders (namely smoking, alcohol, age, sex, BMI, 
LPE, pubertal status and diagnosis), the models with the 
highest  BF10 included the variables smoking, sex and BMI. 
We, therefore, included these variables as covariates in the 
main analyses. For RSE, the best models contained smok-
ing, sex and diagnosis, or smoking and sex. We, therefore, 
only included smoking, sex and diagnosis as covariates in 
the analyses for RSE. Excluding participants with missing 
data, data of 234 participants were available for CESD and 
data of 253 participants for RSE.
Individual models that predicted CES-D scores from a 
fatty acid showed negative regression coefficients with 95% 
credibility intervals without zero for AA [regression coef-
ficient = − 0.14 (95% credibility interval − 0.26 to − 0.03); 
 BF10 = 2.37], DPA [− 0.13 (− 0.25 to − 0.02);  BF10 = 1.08], 
and ObA [− 0.16 (− 0.28 to − 0.05);  BF10 = 350.04] 
(Table 2). This indicates that higher levels of these fatty 
acids in blood are associated with lower depression scores. 
However,  BF10 indicated evidence in favour of the associa-
tion for ObA only (extreme evidence,  BF10 > 100). For AA 
and DPA,  BF10 showed anecdotal evidence in favour of the 
alternative hypothesis. The  BF10 for O3I and DHA were 
below 0.33, which indicates that there is more evidence 
for the  H0, i.e., no association between O3I and DHA, and 
depression.
When all fatty acids were taken in one model as predic-
tors of CES-D  (BF10 for the model = 2.4E + 5), the regres-
sion coefficient for ObA became smaller and its 95% CI con-
tained a zero score [− 0.10 (− 0.22 to 0.03)] (Table 2). The 
regression coefficient of DPA was almost identical to that in 
Table 1  Participants’ 
characteristics
LPE level of parental education, O3I Omega-3 Index
a Smoking was defined as anybody who indicated to smoke more than zero cigarettes per week
b Alcohol units per week was operationalized as number of day per week that alcohol is consumed times 
units per consumption moment
N Mean SD Fatty acid (%wt/wt of 
total FA, except for 
O3I)
N Mean SD
Age (years) 257 14.11 0.50 Omega-3 Index 257 3.77 0.55
Male/female 257 124/133 (48.2/51.8%) – DHA 22:6n-3 257 2.54 0.46
Smoking no/yesa 255 231/24 (89.9/9.3%) – EPA 20:5n-3 257 0.38 0.15
BMI 240 19.98 3.00 DPA 22:5n-3 257 1.22 0.19
Alcohol units per  weekb 256 0.47 1.80 AA 20:4n-6 257 11.16 1.27
LPE 240 5.05 1.5 ObA 22:5n-6 257 0.44 0.10
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the individual model − 0.12 (− 0.25 to 0.02), but 95% CI for 
DPA, as well as for all other fatty acids, contained zero. The 
 BFomit indicated that the model would be improved when 
DHA was omitted  (BFomit > 3). For other acids,  BFomit indi-
ces were not higher than 3 or lower than 0.33, thus removing 
them would not improve or worsen the model.
Bayesian analyses for regressions that predicted the 
RSE score showed no 95% CIs that did not include zero 
(Table 3). When looking at the Bayes factors, there was 
only substantial evidence for an association between ObA 
and RSE  (BF10 = 4.36), for all other fatty acids, and the 
O3I,  BF10 was below 0.33 which indicates more evidence 
for the  H0, i.e., no association between fatty acids and self-
esteem. When all fatty acids were taken in one model as 
predictors of RSE,  BFomit for DHA exceeded the threshold 
values (> 3), which indicates that removing this from the 
model would improve the model that contains all fatty 
acids.
Table 2  Bayesian analyses, fatty acids as predictor for score on the CES-D, both separate and combined in one model
One fatty acid model is a model in which only one predictor of interest is entered (Omega-3 Index, DHA, EPA, AA, DPA, or ObA). All fatty 
acids model is a model in which all fatty acids (DHA, EPA, AA, DPA, and ObA) are entered, i.e., for example the association between DHA and 
self-esteem is corrected for the other fatty acids (EPA, AA, DPA, ObA)
All analyses were adjusted for BMI, smoking (yes/no), and sex
O3I Omega-3 Index, CES-D Centre for Epidemiologic Studies Depression scale
a Credibility intervals are analogous to confidence intervals in traditional statistics
b BF10 refers to the evidence for the model with the specific fatty acid compared to a model with only covariates
c BFomit indicates whether the model improves with the omission of that specific fatty acid.  BFomit numbers above 3 indicate that keeping the vari-
able in the model is not preferable
Predictor fatty acid One fatty acid All fatty acids in one model
Regression 
coefficient
95% credibility  intervala BF10b Regression 
coefficient
95% credibility interval BFomitc
Omega-3 Index − 0.016 − 0.13;0.10 0.14
DHA − 0.04 − 0.16;0.08 0.15 DHA − 0.02 − 0.14;0.10 3.22
EPA 0.06 − 0.06;0.17 0.37 EPA 0.09 − 0.04;0.21 1.40
AA − 0.14 − 0.26;− 0.03 2.37 AA − 0.04 − 0.18;0.11 2.85
DPA − 0.13 − 0.25;−  0.02 1.08 DPA − 0.12 − 0.25;0.02 0.83
ObA − 0.16 − 0.28;− 0.05 350.04 ObA − 0.10 − 0.22;0.03 1.09
Table 3  Bayesian analyses, fatty acids as predictor for score on the RSE, both separate and combined in one model
One fatty acid model is a model in which only one predictor of interest is entered (Omega-3 Index, DHA, EPA AA, DPA or ObA). All fatty 
acids model is a model in which all fatty acids (DHA, EPA, AA, DPA and ObA) are entered, i.e., for example the association between DHA and 
self-esteem is corrected for the other fatty acids (EPA, AA, DPA, ObA)
All analyses were adjusted for smoking (yes/no), sex and diagnosis (yes/no)
RSE Rosenberg Self-Esteem scale
a Credibility intervals are analogous to confidence intervals in traditional statistics
b BF10 refers to the evidence for the model with the specific fatty acid compared to a model with only covariates
c BFomit indicates whether the model improves with the omission of that specific fatty acid. BF omit above 3 indicate that keeping the variable in 
the model is not preferable
Predictor fatty acid One fatty acid All fatty acids in one model
Regression 
coefficient
95% credibility  intervala BF10b Regression 
coefficient
95% credibility interval BFomitc
Omega-3 Index − 0.05 − 0.16;0.07 0.19
DHA − 0.02 − 0.14;0.09 0.15 DHA − 0.004 − 0.12;0.11 3.28
EPA − 0.08 − 0. 19;0.04 0.31 EPA − 0.07 − 0.20;0.05 1.67
AA − 0.004 − 0.12;0.10 0.14 AA − 0.06 − 0.20;0.08 2.26
DPA 0.03 − 0.08;0.15 0.17 DPA 0.08 − 0.05;0.21 1.61
ObA 0.09 − 0.03;0.20 4.36 ObA 0.07 − 0.05;0.20 1.54
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Discussion
Analyses showed Bayes factors that indicated extreme 
evidence for a weak negative association between ObA 
levels and depression score, and substantial evidence for 
a weak positive association between ObA and self-esteem 
score. In other words, more ObA measured in blood cor-
responded with lower depression and higher self-esteem 
scores. There was no substantial evidence for an associa-
tion between any of the other fatty acids and depression/
self-esteem. For DHA, EPA, and O3I there was even evi-
dence for the absence of an association. When the associa-
tions of fatty acids were adjusted for each other’s effects, 
all effect sizes for tested associations decreased and 95% 
credible intervals for regression coefficients contained a 
zero-score. Note that additional non-linear analyses with 
quadratic fatty acid concentrations (not reported here) did 
not show evidence for a quadratic effect.
The evidence for the relation of depression score with 
DHA, EPA and O3I in the current study was in favour 
of the null hypothesis (i.e., no association). Some earlier 
studies in adolescents that used the frequentist hypothesis 
testing showed non-significant associations between fatty 
acids and depression score [38, 79]. However, the disad-
vantage of the frequentist hypothesis testing approach is 
that a non-significant result can either imply that there is 
evidence for the null hypothesis (i.e., there is no associa-
tion) or the data are insensitive in distinguishing the theory 
from the null hypothesis (i.e., nothing follows from the 
data) [80]. Our findings are in contrast to another earlier 
study in adolescents from the general population in which 
an negative association between depression measured with 
the Beck Depression Inventory (BDI) and EPA in adipose 
tissue of adolescents was found (i.e., more EPA, lower 
depression score; analysis was controlled for other fatty 
acids but no correction for multiple testing) [81]. However, 
some researchers have suggested that the CES-D, like used 
in our study, is better at discriminating depression at lower 
levels than the BDI and the CES-D, thus, might be a bet-
ter measure of depression in the general population [82, 
83]. Furthermore, an association between adipose fatty 
acids and brain fatty acids has, to our knowledge, not been 
established, while the association between blood levels 
and brain levels has been established in animal studies 
[84]. Blood levels of fatty acids might, therefore, be a bet-
ter measure for assessing the association between fatty 
acids and depressive feelings.
It is remarkable that the negative associations of ObA 
with depression and self-esteem score became less con-
vincing and the relationship between ObA and depres-
sion score became weaker after correction for other fatty 
acids. We are not aware of earlier studies reporting the 
association between ObA and depression score, although 
studies looking at other omega-6 fatty acids mostly showed 
positive associations (i.e., more omega-6 fatty acids, 
higher depression scores) [85, 86]. ObA can, in the case 
of DHA deficiency, take the place of DHA in the brain 
[87]. Possibly the replacement of DHA by ObA does not 
change the brain functionality and, therefore, a negative 
association between ObA and depression score in the case 
of DHA deficiency can be found. This surprising negative 
association between ObA and depression score does merit 
more research.
Our data provided evidence for absence of associations of 
depression score with DHA, EPA and O3I in this adolescent 
sample, while meta-analyses that included studies in adults 
have shown that LCPUFA supplementation is associated 
with less depressive feelings [42, 88, 89]. One of the pos-
sible explanations for an absent relationship in the current 
study could be that the design of this trial led us to preselect 
participants with an O3I ≤ 5%. In other fatty acid studies, it 
has been suggested that positive associations with O3I are 
only visible at higher O3I levels (i.e., 8% and up). For exam-
ple, in cardiovascular health, an O3I of > 8% is associated 
with the greatest risk reduction and the study of Markhus 
et al. showed a linear relation between O3I and depressive 
symptoms during pregnancy only when the O3I was > 5.1% 
[50, 52]. Such O3I values seem rare in the specific popula-
tion of students of LGSE as we only had to exclude 23 out 
of 286 students for having an O3I > 5%, with the highest O3I 
being around 6.09%. So, such a low O3I seems to be reality 
in this specific target group. Furthermore, whenever an effect 
of omega-3 fatty acids in trials is found it is mostly a small 
effect, which was also true in this sample where the effect 
sizes ranged between 0.001 and 0.15. Such a small effect 
could easily be offset by other environmental factors. This 
might especially be the case in adolescence, a period of life 
characterised by profound changes in brain development, 
but also social and emotional behaviour [90, 91]. Another 
important issue to consider is that most of the studies look-
ing at depression that find significant associations find very 
small effect sizes and do not use Bayesian statistics. In the 
current study, we did find some regression coefficients with 
95% CI that did not include 0 (e.g. AA and DPA predict-
ing depression score). ‘Frequentist’ regressions with SPSS 
software showed comparable regression coefficients that 
were significant (not shown). However, Bayesian analyses 
only revealed anecdotal evidence for these associations. This 
could also be the case for other studies that found significant 
associations.
This study showed that depressive feelings are common 
in adolescents of LGSE; in our sample 29.4% of the ado-
lescents scored ≥ 16 on the CES-D which is indicative for a 
depression. When we used a stricter cut-off point (as some 
suggest for adolescents) of ≥ 22, 17.1% had scores indicative 
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of depression. Although the percentage of adolescents with 
depression in this sample seems to be high, it is similar to 
percentages found in earlier studies in adolescents. Munhoz 
et al., for example, showed that 17% of the Brazilian adoles-
cents had scores indicative for major depression [92]. Grant 
and colleagues (2015) also showed numbers comparable to 
the current study with 22% of the boys and 34.4% of girls 
showing depressive symptoms [93], and Mamalakis et al. 
(2016) observed a similar mean CES-D score (mean of 14.9 
compared to 12.2 in our sample) [81]. Furthermore, it has 
long been known that, from age 13–14 years onward, there is 
a female preponderance of depression [94]. We also showed 
that girls in this sample had a higher incidence of depres-
sion than boys. In the current study, 42.3% of the girls had 
an indication for depression while, for boys, this was 15.6%.
This observational study has a number of limitations. The 
low O3I of the participants and low spread in the O3I could 
have led to low statistical power. However, as we explained 
above, the low O3I seems to be the reality in this specific 
target group. Additionally, covariates included in the analy-
sis such as smoking behaviour, drinking behaviour were 
assessed via self-reports, this could possible lead to bias 
in these covariates. Also note that the recruitment rate (i.e., 
percentage of those invited who decided to participate) was 
approximately 13%, this could limit the external validity. 
However, such recruitment rate is rather common in a school 
setting [95]. Moreover, this was a cross-sectional study and 
can thus not be used for proving causal relationships, experi-
mental studies are needed for more insight in the effects 
of fatty acids in depression and self-esteem in this specific 
target group. One of the main strengths of the current study 
is the use of finger prick blood samples to determine the 
fatty acids status of the adolescents. Moreover, the popula-
tion was rather homogenous and this study is one of the first 
specifically focusing on adolescents of a lower education 
level. Furthermore, we used the Bayesian approach that, in 
contrast to the frequentist approach, can be used to provide 
evidence for the null hypothesis and to compare different 
models without issues concerning multiple testing.
To summarise, our data in Dutch LGSE adolescents 
with a low O3I in blood revealed high depression rates and 
provided extreme evidence for a weak association between 
ObA levels and depression score (more ObA, lower depres-
sion score) and substantial evidence for a weak association 
between ObA and self-esteem score (more ObA, higher self-
esteem). This surprising result calls for more research into 
the role of ObA in depression. Results of the intervention 
study Food2Learn should shed light on the effect of krill oil 
supplementation (high in omega-3 fatty acids) on depressive 
feelings in adolescents of the LGSE.
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